share_log

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

Benzinga ·  Jun 24 06:22

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment